Gender Differences in the Prevalence and Correlates of Psychotropic Medication Use among Older Adults in Israel

被引:0
|
作者
Blumstein, Tzvia [1 ]
Benyamini, Yael [2 ]
Shmotkin, Dov [3 ]
Lerner-Geva, Liat [1 ,4 ]
机构
[1] Chaim Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, IL-52621 Ramat Gan, Israel
[2] Tel Aviv Univ, Bob Shapell Sch Social Work, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Herczeg Inst Aging, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
来源
关键词
TERM BENZODIAZEPINE USE; DRUG-USE; UNITED-STATES; COGNITIVE IMPAIRMENT; ELDERLY POPULATION; GENERAL-POPULATION; MENTAL-DISORDERS; SEX-DIFFERENCES; HIP-FRACTURES; HELP-SEEKING;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: This study evaluates gender differences in the prevalence of psychotropic medications use among elderly Israelis and the socio-demographic, physical and mental health correlates of their use. Method: Data were taken from a national survey that sampled the community-dwelling Jewish population aged 65-94 in Israel. Psychotropic medications were assessed from the list of all medications recorded during a face-to-face interview. The current analysis focused on three medication groups: anxiolytics, sedatives/hypnotics and antidepressants. Results: A significantly higher use of anxiolytics was observed among women compared to men after taking into account their worse physical and mental health. Age, not being married, sleeping problems and depressive symptoms were significant correlates among men while number of non-psychotropic medications, any life trauma and being married correlated with use of anxiolytics and sedatives/hypnotics among women. The use of antidepressants was low in men and women and was related mainly to disability in ADL. Conclusions: This study points to possibly over-prescribing of anxiolytics among women and low detection and treatment of depression among the elderly in general.
引用
收藏
页码:118 / 127
页数:10
相关论文
共 50 条
  • [1] Prevalence and correlates of psychotropic medication use among older adults in Israel: Cross-sectional and longitudinal findings from two cohorts a decade apart
    Blumstein, Tzvia
    Benyamini, Yael
    Chetrit, Angela
    Mizrahi, Eliyahu H.
    Lerner-Geva, Liat
    AGING & MENTAL HEALTH, 2012, 16 (05) : 636 - 647
  • [2] Gender Differences in Potentially Inappropriate Medication Use among Older Adults
    Alwhaibi, Monira
    Balkhi, Bander
    PHARMACEUTICALS, 2023, 16 (06)
  • [3] Prevalence of Psychotropic Medication Use Among Older Adults with Dementia: Meta-Analysis
    Seitz, Dallas
    Sherman, Chelsea
    Kirkham, Julia
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (03): : S154 - S155
  • [4] Prevalence and correlates of medication reminder app 'use and use intention' among older adults
    Ping, Yongjing
    Visaria, Abhijit
    Suppiah, Sumithra Devi
    Tan, Yi Wen
    Malhotra, Rahul
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2022, 6
  • [5] Prevalence and correlates of psychotropic medication use among adults with developmental disabilities: 1970-2000
    Valdovinos, MG
    Schroeder, SR
    Kim, G
    INTERNATIONAL REVIEW OF RESEARCH IN MENTAL RETARDATION, VOL 26, 2003, 26 : 175 - 220
  • [6] Psychotropic Medication Use in Older Adults
    Strauss, Jason
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 2014, 52 (04) : 77 - 94
  • [7] Prevalence and correlates of alcohol use among older adults
    Ruchlin, HS
    PREVENTIVE MEDICINE, 1997, 26 (05) : 651 - 657
  • [8] Psychotropic medication use among older adults assisted in a Brazilian primary care setting: Prevalence and associated factors
    Motter, Fabiane
    Paniz, Vera
    Lopes, Luciane
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 438 - 439
  • [9] Psychotropic Medication Use among Older Adults What All Nurses Need to Know
    Lindsey, Pamela L.
    JOURNAL OF GERONTOLOGICAL NURSING, 2009, 35 (09): : 28 - 38
  • [10] Gender differences in NSAID use among older adults with osteoarthritis
    Dominick, KL
    Ahern, FM
    Gold, CH
    Heller, DA
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (11) : 1566 - 1571